NEW YORK (GenomeWeb) – Asuragen said today that it is collaborating with Thermo Fisher Scientific to develop and commercialize capillary electrophoresis-based in vitro diagnostics.
Asuragen, based in Austin, Texas, will develop diagnostic kits for Thermo Fisher’s 3500 Dx Series Genetic Analyzer CS2 instrument, using its AmplideX PCR/CE technology, which enables the analysis of repetitive DNA sequences, and its AmplideX Reporter analytics and reporting software. The products will be built under design control and manufactured at Asuragen's cGMP facility.